By Kelly Cloonan
Acrivon Therapeutics has appointed Dr. Mansoor Raza Mirza as chief medical officer, effective Wednesday.
Dr. Mirza joins the Watertown, Mass. clinical stage precision medicine company from Denmark's Copenhagen University National Medical Center, where he served as chief oncologist, Acrivon said Monday.
Mirza succeeds Dr. Jean-Marie Cuillerot, who entered the role in January of last year.
Mirza brings decades of clinical research and patient care experience, and specializes in gynecologic malignancies, or cancers affecting female reproductive organs, the company said.
Write to Kelly Cloonan at kelly.cloonan@wsj.com
(END) Dow Jones Newswires
April 07, 2025 18:14 ET (22:14 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。